Fleming v. Bristol-Myers Squibb Co. et al
Paul Victor Fleming, III |
AstraZeneca AB, AstraZeneca LP, AstraZeneca PLC, Bristol-Myers Squibb Co. and AstraZeneca Pharmaceuticals LP |
4:2019cv00352 |
June 28, 2019 |
US District Court for the Northern District of Oklahoma |
Terence Kern |
Frank H McCarthy |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on August 14, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 19 MINUTE ORDER by Judge Terence Kern - In light of the Amended Complaint filed 7/22/2019 (Doc. 15), the Motion to Dismiss for Failure to State a Claim filed by Defendants AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Co.(Doc. 9) is denied as moot. ; finding as moot #9 Motion to Dismiss for Failure to State a Claim (Re: #15 Complaint ) (This entry is the Official Order of the Court. No document is attached.) (lmc, Chambers) |
Filing 18 MINUTE ORDER by Judge Terence Kern - Joint Motion for Extention of Time to File Joint Status Report (Doc. 17) is GRANTED. The deadline to file the Joint Status Report is extended to 9/6/2019. ; setting/resetting deadline(s)/hearing(s): ( Status Report due by 9/6/2019); granting #17 Motion to Accelerate/Extend/Reset Hearing(s)/Deadline(s) (This entry is the Official Order of the Court. No document is attached.) (lmc, Chambers) |
Filing 17 Joint MOTION to Accelerate/Extend/Reset Hearing(s)/Deadline(s) to File Joint Status Report (Re: #13 Order, Directing Parties to File Joint Status Report ) by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co. (Zschiesche, Raymond) |
Filing 16 ATTORNEY APPEARANCE by Stephen D Raber on behalf of All Defendants [Note: Attorney Stephen D Raber added to party AstraZeneca AB(pty:dft), Attorney Stephen D Raber added to party AstraZeneca LP(pty:dft), Attorney Stephen D Raber added to party AstraZeneca PLC(pty:dft).] (Raber, Stephen) |
NOTICE of Docket Entry Modification; Error: wrong event (Complaint); Correction: edited docket text to reflect correct event (Amended Complaint) (Re: #15 Complaint ) (a-srt, Dpty Clk) |
Filing 15 AMENDED COMPLAINT with Jury Demand against All Defendants by Paul Victor Fleming, III (Boudreaux, Paul) Modified on 7/23/2019 to correct event (a-srt, Dpty Clk). |
Filing 14 ATTORNEY APPEARANCE by Matthew David Heins on behalf of AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co. (Heins, Matthew) |
Filing 13 ORDER by Judge Terence Kern for Joint Status Report, directing parties to file joint status report ( Status Report due by 8/12/2019) (lmc, Chambers) |
Filing 12 ORDER by Judge Terence Kern - Matthew David Heins and Stephen D. Raber are admitted Pro Hac Vice for Defendants AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Co. ; granting #10 Motion for Admission Pro Hac Vice; granting #11 Motion for Admission Pro Hac Vice (lmc, Chambers) |
Filing 11 MOTION for Attorney(s) Stephen D. Raber to be Admitted Pro Hac Vice (paid $50 PHV fee; receipt number 1085-2074155) by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co. (With attachments) (Zschiesche, Raymond) |
Filing 10 MOTION for Attorney(s) Matthew David Heins to be Admitted Pro Hac Vice (paid $50 PHV fee; receipt number 1085-2074146) by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co. (With attachments) (Zschiesche, Raymond) |
Filing 9 MOTION to Dismiss for Failure to State a Claim Pursuant to Federal Rule of Civil Procedure 12(b)(6) and Brief in Support Thereof by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co. (Zschiesche, Raymond) |
Filing 8 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP) by AstraZeneca Pharmaceuticals LP (Zschiesche, Raymond) |
Filing 7 CORPORATE DISCLOSURE STATEMENT by Bristol-Myers Squibb Co. (Zschiesche, Raymond) |
Filing 6 STATUS REPORT on Removed Action by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co. (Zschiesche, Raymond) |
Filing 5 MINUTE ORDER by Court Clerk , directing Bristol-Myers Squibb Co. and AstraZeneca Pharmaceuticals LP to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) |
Filing 4 MINUTE ORDER by Court Clerk , : Pursuant to Local Rule 81.2, the removing party(ies) shall file a Status Report on Removed Action within five (5) days of the filing of the notice of removal in the U.S. District Court. The form is available on the Court's website. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) |
Filing 3 ATTORNEY APPEARANCE by Raymond Edward Zschiesche on behalf of AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co. (Zschiesche, Raymond) |
Filing 2 NOTICE of Removal from District Court of Tulsa County, Oklahoma, case number CJ-2019-02220 (paid $400 filing fee; receipt number 1085-2073505) by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co. (With attachments) (Zschiesche, Raymond) |
Filing 1 CIVIL COVER SHEET by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co. (Zschiesche, Raymond) |
PETITION/COMPLAINT filed in State Court against All Defendants by Paul Victor Fleming, III (jln, Dpty Clk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Oklahoma Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.